Apyx Medical Corporation designs and manufactures energy-based surgical devices for cosmetic and medical procedures, primarily through its proprietary Helium Plasma Technology platform, which delivers controlled heat for tissue contouring, skin tightening, and soft tissue treatment with minimal thermal damage compared to alternative technologies. The company sells capital equipment generators and consumable handpieces and cartridges directly to plastic surgeons, cosmetic physicians, and surgical centers in the United States, as well as internationally through distributor networks, while also generating revenue from contract manufacturing agreements with established medical device companies. Apyx operates in the surgical aesthetics market, which is shaped by consumer demand for cosmetic procedures and body contouring treatments, and holds a competitive advantage through its proprietary Helium Plasma Technology and multiple FDA indications, competing primarily against companies offering traditional body contouring solutions.